Febuxostat inhibition of endothelial-bound XO: Implications for targeting vascular ROS production
- 1 July 2011
- journal article
- Published by Elsevier BV in Free Radical Biology & Medicine
- Vol. 51 (1), 179-184
- https://doi.org/10.1016/j.freeradbiomed.2011.04.004
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Nitro-oleic Acid, a Novel and Irreversible Inhibitor of Xanthine OxidoreductasePublished by Elsevier BV ,2008
- Production of extracellular superoxide by human lymphoblast cell lines: Comparison of electron spin resonance techniques and cytochrome C reduction assayBiochemical Pharmacology, 2007
- Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cellsFree Radical Biology & Medicine, 2006
- Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and GoutThe New England Journal of Medicine, 2005
- Binding of Xanthine Oxidase to Glycosaminoglycans Limits Inhibition by OxypurinolPublished by Elsevier BV ,2004
- An Extremely Potent Inhibitor of Xanthine OxidoreductaseJournal of Biological Chemistry, 2003
- Circulating xanthine oxidase and neutrophil activation during human liver transplantationGastroenterology, 1998
- The Reaction of Reduced Xanthine Dehydrogenase with Molecular OxygenPublished by Elsevier BV ,1997
- Serum xanthine oxidase in jaundiceClinica Chimica Acta; International Journal of Clinical Chemistry, 1975
- Serum Xanthine Oxidase and Liver DiseaseDigestion, 1972